Indian pharma firms operating in China have made some headway into the Chinese market winning bids to supply bulk generic ...

Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...

India's drug regulator is tightening quality control measures, demanding compliance from MSME pharmaceutical manufacturers.

For Indian pharmaceutical companies that already supply nearly half of all generic medicines sold in the US, the decision ...

India's drug regulator mandates all pharmaceutical factories comply with international standards by January, rejecting ...

Cipla, Natco, Hetero among Indian firms win bids to supply generic drugs in China. Key drugs include Dapagliflozin.

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...

India's pharma and healthcare sectors saw $3.5 bn in deals in Q3 2025, a 166% surge led by consolidation in pharma, biotech, and hospital segments: Grant Thornton Bharat ...

Indian drugmaker Alembic Pharmaceuticals posted a 20.4% rise in second-quarter profit on Tuesday, aided by strong demand for ...

Indian drugmaker Torrent Pharma reported a 30.5% rise in its second-quarter profit on Friday, driven by strong domestic demand for its cardiovascular and anti-diabetic drugs.

German inks and coatings supplier Siegwerk has introduced a range of mineral oil‑free inks aimed at the Indian pharmaceutical ...

India’s rapid export diversification is strengthening Prime Minister Narendra Modi’s trade leverage just as the US signals readiness for an agreement. During his Asia tour this week, President Donald ...